Successful Treatment of Iron Deficiency Anemia with Ferric Carboxymaltose in an Elderly Patient with Multiple Comorbidities and COVID-19

Vincenzo Bassi; Valentina Apuzzi; Francesco Calderaro; Massimo Piroddi

doi:10.7759/cureus.16997

Successful Treatment of Iron Deficiency Anemia with Ferric Carboxymaltose in an Elderly Patient with Multiple Comorbidities and COVID-19

Cureus. 2021 Aug 8;13(8):e16997. doi: 10.7759/cureus.16997. eCollection 2021 Aug.

Authors

Vincenzo Bassi¹, Valentina Apuzzi¹, Francesco Calderaro¹, Massimo Piroddi¹

Affiliation

¹ U.O.C. di Medicina Generale e Lungodegenza, San Giovanni Bosco Hospital, ASL Napoli 1 Centro, Naples, ITA.

Abstract

Anemia is frequently associated with older age and comorbidities. Also, anemia is a frequent finding in patients hospitalized for Coronavirus infectious disease 2019 (COVID-19), where it has been associated with poor outcomes. Management of anemia is thus crucial in this setting. We present the case of an elderly woman with chronic iron deficiency anemia and multiple comorbidities, hospitalized for COVID-19, whose iron deficiency was successfully treated with ferric carboxymaltose. Hemoglobin and iron stores were replenished, and transferrin saturation increased to average values. Ferric carboxymaltose was well tolerated, and there were no safety concerns. The patient recovered from COVID-19 was discharged 25 days after admission.

Keywords: anemia; covid-19; elderly; ferric carboxymaltose; hospitalization.

Publication types

Case Reports